脑部放疗，上午比下午敏感许多！
" @: r2 X+ w% G
$ d4 n2 F4 W8 }$ d* b' L: N
4 O: A1 F( d% ?5 c- M: NCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
2 q @9 t# X* [6 H* b; B, y5 _Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
& Q0 Y7 D* u$ K$ ~6 l8 N( DRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.: H b; y _3 S+ P7 o& _/ K
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
2 \) @; p ?" p. o: \0 E
) D+ s# C5 F! [6 a" D6 F' z& ]# Q# l1 {Abstract; r7 v J7 \8 t' r' C
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
5 q- Q2 b- F+ `; p2 M! e' P
( g8 L* m& Y: xMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.* n7 p4 J- L/ A8 E, Z% c
1 w; c. p8 [/ S' t) @7 ]' E) Y- {
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
5 M3 M: j& s1 M
0 }( e2 K# l$ Y+ P4 tCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
5 G. i% o/ q; A5 W! k, j3 U! M) c0 X4 u" y: r% r3 R/ a
|
11011102001537 )
+ {0 o7 a+ S8 x' [5 x J) c! L. a
显身卡
